AGP
LEGN icon

Artia Global Partners’s Legend Biotech LEGN Stock Holding History

Artia Global Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,000
Closed -$241K – 39
2023
Q1 		$241K Buy
+5,000
New +$245K 0.09% 35

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artia Global Partners's LEGN Position: Q2 2023 in Review

Artia Global Partners sold out of Legend Biotech (LEGN) in Q2 2023, closing a stake of 5,000 shares — an estimated $241K sold.

Artia Global Partners first reported a position in LEGN in Q1 2023 and held it in 1 quarter. The position peaked at $241K in Q1 2023. 194 funds tracked by Wall St. Rank hold LEGN as of Q2 2023.

  • Artia Global Partners reported no remaining Legend Biotech position as of Q2 2023 after selling out during the quarter.
  • Artia Global Partners sold 5,000 Legend Biotech shares in Q2 2023, an estimated $241K.
  • Artia Global Partners first reported a position in Legend Biotech in Q1 2023 and held it in 1 quarter.
  • Artia Global Partners's Legend Biotech position peaked at $241K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2023.

Based on Artia Global Partners's 13F filing for Q2 2023, filed 14 Aug 2023.